What's Up Docs? Can psychedelics improve your mental health?
11 snips
Sep 30, 2025 Dr. James Rucker, a consultant psychiatrist at King's College London, is leading groundbreaking trials on psilocybin for treatment-resistant depression. He explains how psychedelics stimulate serotonin receptors, offering insights into their potential therapeutic effects. Rucker details the structure of psilocybin therapy, emphasizing the profound benefits patients report, such as improved mood and lasting remission. The discussion also touches on the fine balance of using psychedelics respectfully within cultural contexts and cautioning recreational use.
AI Snips
Chapters
Transcript
Episode notes
Use Structured Therapy Around Dosing
- Offer psychedelics inside a prepared, supportive therapeutic setting with pre- and post-sessions.
- Prepare patients, agree support signals, and guide integration after the dosing session.
Trips Require Intent And Integration
- Psilocybin trips are varied and often 'send you sideways' rather than simply euphoric or sedating.
- Therapeutic work requires patient intention and subsequent integration to translate experiences into lasting change.
Strict Inclusion For Psilocybin Trials
- Recruit participants with defined treatment-resistant depression criteria for trials: failed at least two antidepressants.
- Limit inclusion appropriately to ensure the study targets those who need alternative therapies.